About treatment
![Toolbox](/sites/kise/files/styles/article_full_width/public/qbank/Verktyg-custom20200910135158.jpg?itok=8PJTHkUG)
Treatment targets in these patients is almost exclusively directed against the immune response and there are now several treatment alternatives available all with their advantages and disadvantages. Important for a good treatment (stated from our web survey) is:
- According to patients: Quality of life
- According to physicians: protection against long-term disability
- None of these are very well reflected in standard two year randomized clinical trials.
Treatments used in MS
Generic name | Brand name |
---|---|
Interferon beta (IFNβ) | Avonex, Betaferon, Extavia, Rebif, Plegridy |
Glatiramer acetate (GA) | Copaxone |
Natalizumab | Tysabri |
Fingolimod | Gilenya |
Alemtuzumab | Lemtrada |
Teriflunomide | Aubagio |
Dimethylfumarate | Tecfidera |
Daclizumab | Zinbryta |
Rituximab | Mabthera |
To find detailed description of mode of actions, doses and side effects, please visit the Medical Products Agency or the Swedish MS society and patient organizations.